FDA
approval
· 2014-10-23
FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
Summary
The FDA approved a supplemental application for Tudorza Pressair (aclidinium bromide) submitted by Covis Pharma US, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TUDORZA PRESSAIR (ACLIDINIUM BROMIDE)